Collegium Pharmaceutical, Inc. (COLL)

USD 26.65

(2.54%)

Net Income Summary of Collegium Pharmaceutical, Inc.

  • Collegium Pharmaceutical, Inc.'s latest annual net income in 2023 was 48.15 Million USD , up 292.6% from previous year.
  • Collegium Pharmaceutical, Inc.'s latest quarterly net income in 2024 Q2 was 19.6 Million USD , down -29.25% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported an annual net income of -25 Million USD in 2022, down -134.96% from previous year.
  • Collegium Pharmaceutical, Inc. reported an annual net income of 71.51 Million USD in 2021, up 167.33% from previous year.
  • Collegium Pharmaceutical, Inc. reported a quarterly net income of 27.71 Million USD for 2024 Q1, down -13.23% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported a quarterly net income of -17.42 Million USD for 2023 Q1, down -142.06% from previous quarter.

Annual Net Income Chart of Collegium Pharmaceutical, Inc. (2023 - 2013)

Historical Annual Net Income of Collegium Pharmaceutical, Inc. (2023 - 2013)

Year Net Income Net Income Growth
2023 48.15 Million USD 292.6%
2022 -25 Million USD -134.96%
2021 71.51 Million USD 167.33%
2020 26.75 Million USD 428.33%
2019 -8.14 Million USD 79.18%
2018 -39.12 Million USD 47.74%
2017 -74.86 Million USD 20.51%
2016 -94.17 Million USD -245.54%
2015 -27.25 Million USD -52.12%
2014 -17.91 Million USD -10.62%
2013 -16.19 Million USD 0.0%

Peer Net Income Comparison of Collegium Pharmaceutical, Inc.

Name Net Income Net Income Difference
Intra-Cellular Therapies, Inc. -139.67 Million USD 134.477%
PainReform Ltd. -9.34 Million USD 615.357%
Alvotech -551.73 Million USD 108.728%
ANI Pharmaceuticals, Inc. 18.77 Million USD -156.43%
Aquestive Therapeutics, Inc. -7.87 Million USD 711.881%
Journey Medical Corporation -3.85 Million USD 1349.805%
Dynavax Technologies Corporation -6.38 Million USD 853.717%
Esperion Therapeutics, Inc. -209.24 Million USD 123.013%
Bright Green Corporation -13.12 Million USD 466.821%
Pacira BioSciences, Inc. 41.95 Million USD -14.778%
Embecta Corp. 70.4 Million USD 31.598%
Sunshine Biopharma, Inc. -4.5 Million USD 1168.676%
Sunshine Biopharma, Inc. -4.5 Million USD 1168.676%
SCYNEXIS, Inc. 67.04 Million USD 28.171%
Petros Pharmaceuticals, Inc. -8.16 Million USD 689.904%
Silver Spike Investment Corp. 7.34 Million USD -556.053%
China SXT Pharmaceuticals, Inc. -3.09 Million USD 1654.123%
Alpha Teknova, Inc. -36.78 Million USD 230.927%
Safety Shot Inc -15.08 Million USD 419.266%
Procaps Group, S.A. 42.54 Million USD -13.199%
Cosmos Health Inc. -18.54 Million USD 359.699%
Theratechnologies Inc. -23.95 Million USD 301.006%
Harrow Health, Inc. -24.41 Million USD 297.268%
Sonoma Pharmaceuticals, Inc. -4.83 Million USD 1095.967%
Biofrontera Inc. -20.13 Million USD 339.208%
DURECT Corporation -27.62 Million USD 274.323%
Supernus Pharmaceuticals, Inc. 1.31 Million USD -3559.195%
Cronos Group Inc. -73.96 Million USD 165.107%
OptiNose, Inc. -35.48 Million USD 235.713%
Ironwood Pharmaceuticals, Inc. -1 Billion USD 104.805%
Kala Pharmaceuticals, Inc. -42.19 Million USD 214.114%
RedHill Biopharma Ltd. 23.91 Million USD -101.351%
Organogenesis Holdings Inc. 4.94 Million USD -873.812%
Guardion Health Sciences, Inc. 158.03 Thousand USD -30371.484%
Cumberland Pharmaceuticals Inc. -6.27 Million USD 866.882%
Radius Health, Inc. -25.79 Million USD 286.712%
Universe Pharmaceuticals INC -6.16 Million USD 881.349%
ProPhase Labs, Inc. -16.78 Million USD 386.944%
Phibro Animal Health Corporation 2.41 Million USD -1893.171%
Procaps Group S.A. 42.54 Million USD -13.199%
TherapeuticsMD, Inc. -10.27 Million USD 568.525%
Viatris Inc. 54.7 Million USD 11.965%
Rockwell Medical, Inc. -8.43 Million USD 670.624%
Aytu BioPharma, Inc. -15.84 Million USD 403.932%
SIGA Technologies, Inc. 68.06 Million USD 29.255%
Tilray Brands, Inc. -244.98 Million USD 119.657%
Lifecore Biomedical, Inc. 12.01 Million USD -300.857%
Shineco, Inc. -22.44 Million USD 314.508%
PetIQ, Inc. 2.13 Million USD -2159.737%
Regencell Bioscience Holdings Limited -4.3 Million USD 1219.406%
Incannex Healthcare Limited -18.45 Million USD 360.875%
Neurocrine Biosciences, Inc. 249.7 Million USD 80.715%
Alimera Sciences, Inc. -20.13 Million USD 339.196%
Assertio Holdings, Inc. -331.94 Million USD 114.507%
Shuttle Pharmaceuticals Holdings, Inc. -6.59 Million USD 830.427%
Clever Leaves Holdings Inc. -17.89 Million USD 369.037%
Cyclo Therapeutics, Inc. -20.05 Million USD 340.087%
Avadel Pharmaceuticals plc -160.27 Million USD 130.045%
Hempacco Co., Inc. -13.12 Million USD 466.865%
Talphera, Inc. -18.39 Million USD 361.755%
Alvotech -551.73 Million USD 108.728%
Eagle Pharmaceuticals, Inc. 35.64 Million USD -35.107%
Lantheus Holdings, Inc. 326.66 Million USD 85.258%
Currenc Group, Inc. -15.3 Million USD 414.604%
Kamada Ltd. 8.28 Million USD -481.301%
Indivior PLC 2 Million USD -2307.75%
Evoke Pharma, Inc. -7.79 Million USD 717.982%
Flora Growth Corp. -57.03 Million USD 184.429%
Cyclo Therapeutics, Inc. -20.05 Million USD 340.087%
Evolus, Inc. -61.68 Million USD 178.066%
HUTCHMED (China) Limited 100.78 Million USD 52.218%
Amphastar Pharmaceuticals, Inc. 137.54 Million USD 64.99%
Akanda Corp. -32.27 Million USD 249.202%